- Home
- GO vs ALVO Comparison
GO vs ALVO Comparison
Compare GO & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GO | ALVO |
|---|---|---|
| Founded | 1946 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | GO | ALVO |
|---|---|---|
| Price | $11.36 | $5.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $15.50 | $10.67 |
| AVG Volume (30 Days) | ★ 2.5M | 611.8K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $4,571,346,000.00 | $573,350,000.00 |
| Revenue This Year | $10.74 | $20.97 |
| Revenue Next Year | $5.25 | $43.04 |
| P/E Ratio | ★ N/A | $22.78 |
| Revenue Growth | 7.22 | ★ 45.55 |
| 52 Week Low | $10.21 | $4.32 |
| 52 Week High | $19.97 | $13.70 |
Technical Indicators
Market Signals| Indicator | GO | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 40.48 | 46.79 |
| Support Level | $10.82 | $4.32 |
| Resistance Level | $11.44 | $5.49 |
| Average True Range (ATR) | 0.42 | 0.29 |
| MACD | 0.23 | 0.10 |
| Stochastic Oscillator | 84.62 | 97.87 |
Price Performance
Historical ComparisonAbout GO Grocery Outlet Holding Corp.
Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.